You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Osteoporosis

Denosumab for the prevention of osteoporotic fractures in postmenopausal women

  • Technology appraisal guidance
  • Reference number: TA204
  • Published:  27 October 2010
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Consultee and commentator comments on the ACD

  • Amgen

  • Society for Endocrinology

  • Royal College of Nursing

  • Novartis

  • Servier Laboratories

  • Warner Chilcott UK

  • National Osteoporosis Society


This page was last updated: 07 October 2010

Back to top